FOR IMMEDIATE RELEASE

NOTICE OF PALADIN LAB'S THIRD QUARTER RESULTS CONFERENCE CALL

Montreal, Canada, October 20, 2005 - Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today announced that it will report its 2005 third quarter financial results on Thursday, October 27, 2005 prior to market opening. Following the release, Paladin will hold a conference call at 10:00 a.m. (EST) hosted by Jonathan Ross Goodman, President and CEO of Paladin Labs. Paladin cordially invites all interested parties to participate in this call.

CONFERENCE CALL DETAILS:

DATE:	Thursday, October 27, 2005
TIME:	10:00 a.m. EST
DIAL IN NUMBER:	1-888-789-0150 or 416-695-6120
TAPED REPLAY:	1-888-509-0081 or 416-695-5275 Available from Thursday, October 27th at noon until Thursday, November 3rd at midnight

The call will also be audio-cast live and archived for 90 days at www.paladinlabs.com.

About Paladin Labs Inc.
Paladin Labs Inc., headquartered in Montreal, Quebec, is a leading specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada’s leading specialty pharmaceutical companies. Paladin’s shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Paladin web site at www.paladinlabs.com

For further information please contact:

Paladin Labs Inc.
Samira Sakhia, Chief Financial Officer
Tel: 514-340-5067
e-mail: info@paladin-labs.com
Web Site: www.paladinlabs.com